EFMH
JAZZ icon

E Fund Management (HK)’s Jazz Pharmaceuticals JAZZ Stock Holding History

E Fund Management (HK)’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.5K Buy
114
+35
+44% +$7.67K 0.01% 252
2026
Q1 		$14.9K Buy
+79
New +$13.8K 0.01% 252

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

E Fund Management (HK)'s JAZZ Position: Q2 2026 in Review

E Fund Management (HK) increased its Jazz Pharmaceuticals (JAZZ) stake by 44% in Q2 2026, buying an estimated $7.67K and bringing the position to 114 shares worth $27.5K. The position accounts for 0.01% of the portfolio, ranked #252.

E Fund Management (HK) first reported a position in JAZZ in Q1 2026 and has held it in 2 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • E Fund Management (HK) held 114 shares of Jazz Pharmaceuticals worth $27.5K as of Q2 2026.
  • E Fund Management (HK) bought 35 Jazz Pharmaceuticals shares in Q2 2026, an estimated $7.67K.
  • Jazz Pharmaceuticals made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #252 holding.
  • E Fund Management (HK) first reported a position in Jazz Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.